Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-10-018434
Filing Date
2010-05-03
Accepted
2010-05-03 12:25:52
Documents
1
Period of Report
2010-03-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5731
  Complete submission text file 0001140361-10-018434.txt   7599
Mailing Address 27 MARATHONOS AVE. 15351 ATHENS J3 00000
Business Address 27 MARATHONOS AVE. 15351 ATHENS J3 00000 30-210-603-4026
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 90, FAIRMOUNT ROAD WEST CALIFON NJ 07830-3330
Business Address
Durrant Cameron (Reporting) CIK: 0001421882 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51652 | Film No.: 10790546